{"entity":{"type":"insider","cik":"0001477126","url":"/insider/0001477126","json_url":"/insider/0001477126.json","name":"Durham Mark Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2010-08-20","last":"2011-05-13","span_basis":"filed_date"},"name_variants":[{"name":"Durham Mark Andrew","source":"filing","n_filings":2,"first_seen":"2010-08-20","last_seen":"2011-05-13"}],"transactions":[{"id":8991517,"accession":"0000885590-11-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000885590-11-000025","line_url":"/filing/0000885590-11-000025#line-2","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"Valeant Pharmaceuticals International, Inc.","issuer_ticker":"VRX","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001477126","owner_name":"Durham Mark Andrew","owner_url":"/insider/0001477126","role":"Officer (SVP Human Resources)","officer_title":"SVP Human Resources","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":52.17,"price_display":"52.17","price_state":"stated","total_value":2608500.0,"total_display":"2,608,500.00","shares_owned_after":61595.0,"shares_owned_after_display":"61,595","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-11","filed_date":"2011-05-13","scope":"insider"},{"id":7556594,"accession":"0000885590-10-000034","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000885590-10-000034","line_url":"/filing/0000885590-10-000034#line-3","is_derivative":false,"issuer_cik":"0000885590","issuer_name":"BIOVAIL Corp","issuer_ticker":"BVF","issuer_name_source":null,"issuer_url":"/issuer/0000885590","owner_cik":"0001477126","owner_name":"Durham Mark Andrew","owner_url":"/insider/0001477126","role":"Officer (SVP, HR & Shared Services)","officer_title":"SVP, HR & Shared Services","security_title":"Common Stock, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":22.26,"price_display":"22.26","price_state":"stated","total_value":1335600.0,"total_display":"1,335,600.00","shares_owned_after":1250.0,"shares_owned_after_display":"1,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-20","filed_date":"2010-08-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000885590","name":"Valeant Pharmaceuticals International, Inc.","url":"/issuer/0000885590","role":"Officer (SVP Human Resources)","n_filings":2,"first_seen":"2010-08-20","last_seen":"2011-05-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001477126","retrieved_at":"2026-08-21T18:50:58+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}